Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages

被引:155
作者
Eissner, G
Kirchner, S
Lindner, H
Kolch, W
Janosch, P
Grell, M
Scheurich, P
Andreesen, R
Holler, E
机构
[1] Univ Regensburg, Dept Hematol & Oncol, D-93053 Regensburg, Germany
[2] Univ Stuttgart, Inst Immunl & Cell Biol, D-7000 Stuttgart, Germany
[3] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
关键词
D O I
10.4049/jimmunol.164.12.6193
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously reported that the CD14(+) monocytic subpopulation of human PBMC induces programmed cell death (apoptosis) in cocultured endothelial cells (EC) when stimulated by bacterial endotoxin (LPS), Apoptosis is mediated by two routes, first via transmembrane TNF-alpha (mTNF) expressed on PBMC and, in addition, by TNF-independent soluble factors that trigger apoptosis in EC, Neutralizing anti-TNF mAb completely blocked coculture-mediated apoptosis, despite the fact that there should have been additional soluble cell death factors. This led to the hypothesis that a reverse signal is transmitted from the TNF receptor on EC to monocytes (MO) via mTNF that prevents the production of soluble apoptotic factors. Here we have tested this hypothesis. The results support the idea of a bidirectional cross-talk between MO and EC, Peripheral blood MO, MO derived macrophages (M Phi), or the monocytic cell line Mono Mac 6 were preincubated with human microvascular EC that constitutively express TNF receptor type I (TNF-R1) and subsequently stimulated with LPS. Cell-free supernatants of these preparations no longer induced EC apoptosis, The preincubation of MO/M Phi with TNF-reactive agents, such as mAb and soluble receptors, also blocked the production of death factors, providing further evidence for reverse signaling via mTNF, Finally, we show that reverse signaling through mTNF mediated LPS resistance in MO/M Phi as indicated by the down-regulation of LPS-induced soluble TNF and IL-6 as well as IL-1 and IL-10.
引用
收藏
页码:6193 / 6198
页数:6
相关论文
共 25 条
  • [1] HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE
    ADES, EW
    CANDAL, FJ
    SWERLICK, RA
    GEORGE, VG
    SUMMERS, S
    BOSSE, DC
    LAWLEY, TJ
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) : 683 - 690
  • [2] ANDREESEN R, 1986, BLOOD, V67, P1257
  • [3] COTTER TG, 1992, CANCER RES, V52, P997
  • [4] CRITICAL INVOLVEMENT OF TRANSMEMBRANE TUMOR-NECROSIS-FACTOR-ALPHA IN ENDOTHELIAL PROGRAMMED CELL-DEATH MEDIATED BY IONIZING-RADIATION AND BACTERIAL-ENDOTOXIN
    EISSNER, G
    KOHLHUBER, F
    GRELL, M
    UEFFING, M
    SCHEURICH, P
    HIEKE, A
    MULTHOFF, G
    BORNKAMM, GW
    HOLLER, E
    [J]. BLOOD, 1995, 86 (11) : 4184 - 4193
  • [5] ANTITUMOR NECROSIS FACTOR MODULATES ANTI-CD3-TRIGGERED T-CELL CYTOKINE GENE-EXPRESSION IN-VIVO
    FERRAN, C
    DAUTRY, F
    MERITE, S
    SHEEHAN, K
    SCHREIBER, R
    GRAU, G
    BACH, JF
    CHATENOUD, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) : 2189 - 2196
  • [6] Georgopoulos S, 1996, J INFLAMM, V46, P86
  • [7] THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR
    GRELL, M
    DOUNI, E
    WAJANT, H
    LOHDEN, M
    CLAUSS, M
    MAXEINER, B
    GEORGOPOULOS, S
    LESSLAUER, W
    KOLLIAS, G
    PFIZENMAIER, K
    SCHEURICH, P
    [J]. CELL, 1995, 83 (05) : 793 - 802
  • [8] GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143
  • [9] MODULATION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) RELEASE IN THE COURSE OF PRETRANSPLANT CONDITIONING - ROLE OF CONDITIONING REGIMENS AND PROPHYLACTIC APPLICATION OF A MONOCLONAL-ANTIBODY NEUTRALIZING HUMAN TNF-ALPHA (MAK 195F)
    HOLLER, E
    KOLB, HJ
    MITTERMULLER, J
    KAUL, M
    LEDDEROSE, G
    DUELL, T
    SEEBER, B
    SCHLEUNING, M
    HINTERMEIERKNABE, R
    ERTL, B
    KEMPENI, J
    WILMANNS, W
    [J]. BLOOD, 1995, 86 (03) : 890 - 899
  • [10] Karsan A, 1996, J Atheroscler Thromb, V3, P75